These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8294111

  • 1. Transgenic mouse models of hepatocellular carcinoma.
    Gordon JW.
    Hepatology; 1994 Feb; 19(2):538-9. PubMed ID: 8294111
    [No Abstract] [Full Text] [Related]

  • 2. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
    Geller SA, Nichols WS, Kim S, Tolmachoff T, Lee S, Dycaico MJ, Felts K, Sorge JA.
    Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096
    [Abstract] [Full Text] [Related]

  • 3. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
    Rudnick DA, Liao Y, An JK, Muglia LJ, Perlmutter DH, Teckman JH.
    Hepatology; 2004 Apr; 39(4):1048-55. PubMed ID: 15057909
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
    Perlmutter DH.
    Pediatr Res; 2006 Aug; 60(2):233-8. PubMed ID: 16864711
    [Abstract] [Full Text] [Related]

  • 5. Iron, HCV, and liver cancer: hard metal setting the pace?
    Mueller S, Afdhal NH, Schuppan D.
    Gastroenterology; 2006 Jun; 130(7):2229-34. PubMed ID: 16762645
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatocarcinogenesis: a dynamic cellular perspective.
    Farber E, Sarma DS.
    Lab Invest; 1987 Jan; 56(1):4-22. PubMed ID: 3025514
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human and mouse hepatocellular adenoma and carcinoma display similar tumorigenesis pathway alterations.
    Zucman-Rossi J.
    J Hepatol; 2008 May; 48(5):884-6. PubMed ID: 18314218
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Hepatocellular carcinoma in patients with metabolic liver disease].
    Takeuchi Y, Sugimoto M.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():469-73. PubMed ID: 11761995
    [No Abstract] [Full Text] [Related]

  • 17. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
    Furutani T, Hino K, Okuda M, Gondo T, Nishina S, Kitase A, Korenaga M, Xiao SY, Weinman SA, Lemon SM, Sakaida I, Okita K.
    Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [T cell response to hepatitis B and C: from viral elimination to hepatocellular carcinoma].
    Thimme R, Spangenberg HC, Von Weizsäcker F, Blum HE.
    Dtsch Med Wochenschr; 2002 Oct 25; 127(43):2277-9. PubMed ID: 12397543
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.